Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$809M |
| 2 |
Apple
AAPL
|
+$675M |
| 3 |
Microsoft
MSFT
|
+$499M |
| 4 |
SPDR Gold Trust
GLD
|
+$433M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$486M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$464M |
| 3 |
Alibaba
BABA
|
+$412M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$336M |
| 5 |
RTX Corp
RTX
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.57% |
| 2 | Financials | 6.64% |
| 3 | Healthcare | 6.11% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Communication Services | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
PUT
Gold Fields
GFI
$33.4B
| $98K | ﹤0.01% |
24,300
-75,300
| -76% | -$307K |
|
5302
NRC Health Common Stock
NRC
$432M
| $98K | ﹤0.01% |
3,352
+1,673
| +100% | +$56.1K |
|
5303
BRC Group Holdings
RILY
$308M
| $98K | ﹤0.01% |
5,027
+690
| +16% | +$13.1K |
|
5304
CALL
Texas Roadhouse
TXRH
$13.7B
| $98K | ﹤0.01% |
1,700
-2,200
| -56% | -$126K |
|
5305
Victory Capital Holdings
VCTR
$6.25B
| $98K | ﹤0.01% |
+7,948
| New | +$100K |
|
|
VNET
5306
CALL
VNET Group
VNET
$2.06B
| $98K | ﹤0.01% |
14,200
+4,100
| +41% | +$33.7K |
|
|
ANH
5307
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $98K | ﹤0.01% |
20,287
+4,857
| +31% | +$24K |
|
|
SN
5308
PUT
DELISTED
Sanchez Energy Corporation
SN
| $98K | ﹤0.01% |
31,300
-59,700
| -66% | -$247K |
|
5309
Celldex Therapeutics
CLDX
$3.22B
| $97K | ﹤0.01% |
2,790
+1,399
| +101% | +$54.2K |
|
5310
PUT
CVR Energy
CVI
$3.14B
| $97K | ﹤0.01% |
3,200
+2,800
| +700% | +$94.1K |
|
5311
Franklin Covey
FC
$247M
| $97K | ﹤0.01% |
3,605
+1,179
| +49% | +$32.1K |
|
5312
PUT
KBR
KBR
$4.58B
| $97K | ﹤0.01% |
6,000
+1,200
| +25% | +$21.8K |
|
5313
Morningstar
MORN
$7.48B
| $97K | ﹤0.01% |
1,016
-1,555
| -60% | -$150K |
|
|
NVEE
5314
DELISTED
NV5 Global
NVEE
| $97K | ﹤0.01% |
6,988
+1,712
| +32% | +$21.1K |
|
5315
State Street SPDR S&P Dividend ETF
SDY
$23.8B
| $97K | ﹤0.01% |
1,068
+1,000
| +1,471% | +$93.5K |
|
|
TTPH
5316
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $97K | ﹤0.01% |
1,575
-1,897
| -55% | -$167K |
|
|
FINL
5317
PUT
DELISTED
Finish Line
FINL
| $97K | ﹤0.01% |
7,200
-79,900
| -92% | -$922K |
|
5318
CALL
Ameren
AEE
$30.2B
| $96K | ﹤0.01% |
1,700
-4,000
| -70% | -$221K |
|
5319
CALL
Compañía de Minas Buenaventura
BVN
$8.38B
| $96K | ﹤0.01% |
6,300
-1,000
| -14% | -$15.1K |
|
5320
Invesco CurrencyShares Swiss Franc Trust
FXF
$398M
| $96K | ﹤0.01% |
+980
| New | +$97.4K |
|
5321
Galectin Therapeutics
GALT
$203M
| $96K | ﹤0.01% |
+20,123
| New | +$93.8K |
|
5322
CALL
International Flavors & Fragrances
IFF
$22.5B
| $96K | ﹤0.01% |
+700
| New | +$101K |
|
5323
iShares US Aerospace & Defense ETF
ITA
$14.8B
| $96K | ﹤0.01% |
972
| – | – |
|
5324
Northeast Bank
NBN
$1.14B
| $96K | ﹤0.01% |
4,648
+65
| +1% | +$1.46K |
|
5325
CALL
Prospect Capital
PSEC
$1.09B
| $96K | ﹤0.01% |
14,700
+4,500
| +44% | +$30K |
|
Similar funds
Barclays's Q1 2018 Portfolio in Review
As of Q1 2018, Barclays held 7,683 positions worth $131B, up 6.9% from $122B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $8.37B of net new capital in Q1 2018, opening 561 new positions and adding to 3,709 existing holdings. Its largest new stake was Invesco KBW Bank ETF: 755,000 shares worth $41.5M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $486M trimmed.
- Barclays's largest Q1 2018 buy was Invesco KBW Bank ETF: 755,000 shares worth $41.5M.
- Barclays added most to iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2018, an estimated $809M increase.
- Barclays's biggest Q1 2018 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $486M.
- Barclays fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $53.4M.
- Barclays's ten largest holdings make up 25% of its $131B portfolio in Q1 2018.
- Barclays opened 561 new positions and closed 395 in Q1 2018.
- Barclays's portfolio value rose 6.9% quarter-over-quarter to $131B.
Based on Barclays's 13F filing for Q1 2018, filed 15 May 2018.